Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 176.7M | 179.5M | 179.6M | 178.9M |
Cost of revenue | 49.6M | 48.5M | 47.9M | 48.1M |
Gross profit | 127.1M | 131.0M | 131.7M | 130.9M |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.0M | 3.6M | 2.6M | 3.1M |
Operating income | 127.0M | 130.3M | 132.8M | 130.5M |
Non operating interest income | ||||
Income | 611K | 740K | 673K | 624K |
Expense | 36.9M | 38.3M | 37.9M | 36.9M |
Other income expense | — | — | — | — |
Pretax income | -15.2M | 106.5M | 81.3M | 101.1M |
Tax provision | 9.9M | 18.2M | 18.1M | 18.8M |
Net income | -25.0M | 88.4M | 63.3M | 82.3M |
Basic EPS | 0.0 | 0.0 | 0.0 | 0.0 |
Diluted EPS | 0.0 | 0.0 | 0.0 | 0.0 |
Basic average shares | 5.1B | 5.1B | 5.0B | 5.0B |
Diluted average shares | 5.1B | 5.1B | 5.0B | 5.0B |
EBITDA | 44.2M | 135.4M | 141.8M | 134.0M |
Net income from continuing op. | -25.0M | 88.4M | 63.3M | 82.3M |
Minority interests | -918K | -208K | -274K | 275K |
Preferred stock dividends | 5.6M | 5.7M | 6.9M | 6.1M |